Annual Operating Expenses
$363.14 M
+$9.29 M+2.63%
December 31, 2023
Summary
- As of February 8, 2025, PACB annual total operating expenses is $363.14 million, with the most recent change of +$9.29 million (+2.63%) on December 31, 2023.
- During the last 3 years, PACB annual operating expenses has risen by +$226.19 million (+165.16%).
- PACB annual operating expenses is now at all-time high.
Performance
PACB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$72.91 M
-$15.67 M-17.69%
September 30, 2024
Summary
- As of February 8, 2025, PACB quarterly total operating expenses is $72.91 million, with the most recent change of -$15.67 million (-17.69%) on September 30, 2024.
- Over the past year, PACB quarterly operating expenses has dropped by -$15.67 million (-17.69%).
- PACB quarterly operating expenses is now -24.02% below its all-time high of $95.96 million, reached on December 31, 2023.
Performance
PACB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PACB Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | -17.7% |
| 3 y3 years | +165.2% | +23.3% |
| 5 y5 years | +188.0% | +108.2% |
PACB Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.2% | -24.0% | at low |
| 5 y | 5-year | at high | +168.8% | -24.0% | +141.9% |
| alltime | all time | at high | +1321.1% | -24.0% | +261.1% |
Pacific Biosciences Of California Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $72.91 M(-17.7%) |
| Jun 2024 | - | $88.58 M(-4.5%) |
| Mar 2024 | - | $92.71 M(-3.4%) |
| Dec 2023 | $363.14 M(+2.6%) | $95.96 M(+4.7%) |
| Sep 2023 | - | $91.69 M(+5.7%) |
| Jun 2023 | - | $86.75 M(-2.3%) |
| Mar 2023 | - | $88.76 M(+1.3%) |
| Dec 2022 | $353.85 M(+49.3%) | $87.63 M(+4.5%) |
| Sep 2022 | - | $83.89 M(-6.4%) |
| Jun 2022 | - | $89.60 M(-3.4%) |
| Mar 2022 | - | $92.74 M(+16.1%) |
| Dec 2021 | $237.02 M(+73.1%) | $79.90 M(+35.2%) |
| Sep 2021 | - | $59.11 M(+15.2%) |
| Jun 2021 | - | $51.33 M(+9.9%) |
| Mar 2021 | - | $46.69 M(+32.0%) |
| Dec 2020 | $136.95 M(+1.4%) | $35.38 M(+13.2%) |
| Sep 2020 | - | $31.24 M(+3.7%) |
| Jun 2020 | - | $30.14 M(-25.0%) |
| Mar 2020 | - | $40.20 M(+30.3%) |
| Dec 2019 | $135.12 M(+7.2%) | $30.85 M(-11.9%) |
| Sep 2019 | - | $35.03 M(+3.0%) |
| Jun 2019 | - | $33.99 M(-3.6%) |
| Mar 2019 | - | $35.25 M(-3.1%) |
| Dec 2018 | $126.08 M(+1.3%) | $36.37 M(+30.5%) |
| Sep 2018 | - | $27.86 M(-9.0%) |
| Jun 2018 | - | $30.61 M(-2.0%) |
| Mar 2018 | - | $31.25 M(+4.1%) |
| Dec 2017 | $124.44 M(+7.8%) | $30.02 M(+0.8%) |
| Sep 2017 | - | $29.80 M(-8.0%) |
| Jun 2017 | - | $32.39 M(+0.5%) |
| Mar 2017 | - | $32.24 M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $115.40 M(+9.3%) | $29.25 M(-0.4%) |
| Sep 2016 | - | $29.37 M(+2.3%) |
| Jun 2016 | - | $28.71 M(+2.3%) |
| Mar 2016 | - | $28.07 M(+2.0%) |
| Dec 2015 | $105.63 M(+22.5%) | $27.53 M(+2.0%) |
| Sep 2015 | - | $26.98 M(+4.3%) |
| Jun 2015 | - | $25.86 M(+2.4%) |
| Mar 2015 | - | $25.25 M(+13.1%) |
| Dec 2014 | $86.26 M(+2.7%) | $22.33 M(+3.5%) |
| Sep 2014 | - | $21.57 M(+0.7%) |
| Jun 2014 | - | $21.43 M(+2.4%) |
| Mar 2014 | - | $20.92 M(+3.6%) |
| Dec 2013 | $83.96 M(-11.9%) | $20.19 M(-4.6%) |
| Sep 2013 | - | $21.18 M(+0.6%) |
| Jun 2013 | - | $21.06 M(-2.2%) |
| Mar 2013 | - | $21.54 M(-3.5%) |
| Dec 2012 | $95.28 M(-22.4%) | $22.32 M(-2.0%) |
| Sep 2012 | - | $22.77 M(-0.3%) |
| Jun 2012 | - | $22.83 M(-16.6%) |
| Mar 2012 | - | $27.36 M(+12.9%) |
| Dec 2011 | $122.79 M(-13.5%) | $24.23 M(-26.1%) |
| Sep 2011 | - | $32.77 M(+7.2%) |
| Jun 2011 | - | $30.56 M(-13.3%) |
| Mar 2011 | - | $35.24 M(-4.4%) |
| Dec 2010 | $141.91 M(+60.9%) | $36.87 M(-9.9%) |
| Sep 2010 | - | $40.92 M(+22.9%) |
| Jun 2010 | - | $33.30 M(+8.1%) |
| Mar 2010 | - | $30.82 M(+9.3%) |
| Dec 2009 | $88.20 M(+93.0%) | $28.21 M(+14.8%) |
| Sep 2009 | - | $24.57 M |
| Dec 2008 | $45.71 M(+78.9%) | - |
| Dec 2007 | $25.55 M | - |
FAQ
- What is Pacific Biosciences of California annual total operating expenses?
- What is the all time high annual operating expenses for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual operating expenses year-on-year change?
- What is Pacific Biosciences of California quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly operating expenses year-on-year change?
What is Pacific Biosciences of California annual total operating expenses?
The current annual operating expenses of PACB is $363.14 M
What is the all time high annual operating expenses for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total operating expenses is $363.14 M
What is Pacific Biosciences of California annual operating expenses year-on-year change?
Over the past year, PACB annual total operating expenses has changed by +$9.29 M (+2.63%)
What is Pacific Biosciences of California quarterly total operating expenses?
The current quarterly operating expenses of PACB is $72.91 M
What is the all time high quarterly operating expenses for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total operating expenses is $95.96 M
What is Pacific Biosciences of California quarterly operating expenses year-on-year change?
Over the past year, PACB quarterly total operating expenses has changed by -$15.67 M (-17.69%)